Received Mar 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
recived expired dose of Arexvy; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 60-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 24-FEB-2025) for prophylaxis. On 07-MAR-2025, the patient received the 1st dose of Arexvy. On 07-MAR-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: recived expired dose of Arexvy). The outcome of the expired vaccine used was not applicable. Additional Information: GSK receipt date: 10-MAR-2025 The director of a site explained that they administered an expired dose of Arexvy vaccine which led to, expired vaccine used. It was the first dose of a Respiratory Syncytial Virus vaccine for this patient. The reporter did not had lot number for the vaccine. The Vaccine Administration Facility is the same as Primary Reporter.